Nesa obtains US FDA 510(k) for fibroid mapping tech
Indian femtech Nesa Medtech has received the United States Food and Drug Administration 510(k) clearance for its fibroid mapping tool.
Its Fibroid Mapping Reviewer Application assists in the diagnosis and planning of interventional procedures for patients with uterine fibroids. It generates a 3D model of the uterus from ultrasound images where...
Student athletes will now be donning Fitbits in an effort to study the connection between illnesses and wearable device tracking.
On April 1, the Pac-12 Conference announced a research collaboration with Fitbit and researchers at Stanford Medicine to study whether wearable devices can help detect and track infectious diseases like COVID-19.
About 1,000 student athletes across all Pac-12...
Attacking misinformation head on. Big tech's war against online misinformation is raging hotter than ever with COVID-19. The latest update: Facebook will begin directly contacting users who liked, reacted or commented on "harmful misinformation" about the virus that was later removed by the social network. Facebook wrote this morning that the messages are set to deploy within the coming weeks,...
Data and digital health tech were the focus of Stanford Medicine’s 2020 Health Trends Report.
Released late last week, the research survey of more than 700 physicians, residents and medical students found that many of these respondents are looking forward to incorporating these new tools into their practice.
“We found that current and future physicians are not only open to new technologies but...
This weekend, Stanford Medicine researchers presented the long-awaited results of the Apple Heart Study, which explored the performance of the Apple Watch’s heart rate sensor and an accompanying algorithm in detecting potential arrhythmias.
Funded by Apple and launched back in 2017, the research project enrolled 419,297 Apple Watch and iPhone owners. Among these users, 2,161 (roughly 0.5 percent...
The acceptability, safety, feasibility and preliminary efficacy of Meru Health’s digital therapeutic for depression will be evaluated in a new two-year investigation conducted by Stanford Medicine and VA Palo Alto Health Care System researchers.
According to a clinicaltrials.gov listing, the research program will enroll older adults aged at least 40 years with depressive symptoms in two studies...
The Apple Heart Study — which began enrollment at the end of November — has now begun data collection, with participants receiving prompts over the weekend to sign informed consent documents and initiate data collection. That document also reveals some new details about how Apple plans to use data collected during the study.
“This study is part of the development of a new investigational device...
Cardinal Analytx, a new population health management company founded by Cardinal Partners investor Thomas McKinley based on research from Stanford University, has raised $6.1 million. Cardinal Partners led the round, with participation from the Stanford-StartX Fund and Premera Blue Cross, which also participated in a large pilot study that has provided some initial validation for the company.
The...
Hearing the word “precision” in healthcare typically conjures ideas of cutting edge technologies and treatments like targeted genetic therapy. But it has another meaning in primary care: leveraging data from a variety of sources to deliver personalized, preventive care.
“It’s a way to bring the big data – whether that is on the population level, from digital health devices like wearables, or...
San Mateo, California-based Evidation Health, which was launched last year by GE Ventures and Stanford Healthcare, has raised $10 million from Sanofi-Genzyme BioVentures. GE Ventures and B Capital were return investors, and both firms participated in the efficacy-focused company’s $3.4 million round in October 2016. The latest investment brings the company’s total funding to at least $31 million...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
